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Valde JP, Lawson LG, Lindberg A, Agger JF, Saloniemi H, Østerås O: Cumulative
risk of bovine mastitis treatments in Denmark, Finland, Norway and Sweden. Acta
vet. scand. 2004, 45, 201-210. – Data from the national dairy cow recording systems
during 1997 were used to calculate lactation-speciﬁc cumulative risk of mastitis treat-
ments and cumulative risk of removal from the herds in Denmark, Finland Norway and
Sweden. Sweden had the lowest risk of recorded mastitis treatments during 305 days of
lactation and Norway had the highest risk. The incidence risk of recorded mastitis treat-
ments during 305 days of lactation in Denmark, Finland, Norway and Sweden was
0.177, 0.139, 0.215 and 0.127 for ﬁrst parity cows and 0.228, 0.215, 0.358 and 0.204 for
parities higher than three, respectively. The risk of a ﬁrst parity cow being treated for
mastitis was almost 3 times higher at calving in Norway than in Sweden. The period
with the highest risk for mastitis treatments was from 2 days before calving until 14 days
after calving and the highest risk for removal was from calving to 10 days after calving
in all countries.
The study clearly demonstrated differences in bovine mastitis treatment patterns among
the Nordic countries. The most important ﬁndings were the differences in treatment
risks during different lactations within each country, as well as differences in strategies
with respect to the time during lactation mastitis was treated.
Data recording; mastitis treatment; Nordic countries; dairy herds; cumulative inci-
dence risk; culling.
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Introduction
Mastitis is generally regarded as the most fre-
quent and costly disease in dairy cows world-
wide. Depending on differences in manage-
ment practices and animal care, the impact of
the disease varies between herds. Some farmers
detect mastitis in their dairy cattle quite often,
while others rarely treat their cows for clinical
mastitis (CM) (Barkema et al. 1998). The rate
of new infections within a herd is increased by
management factors that facilitate the spread of
pathogens from the environment to the cows or
from cow to cow (Østerås & Lund 1988,
Barkema et al. 1999). At herd level, a mastitis
problem can be expressed as high bulk milk so-
matic cell count (BMSCC), high proportion of
cows with high individual cow milk somatic
cell counts (CMSCC), high rate of CM treat-
ments or high culling rate because of mastitis.
Annual reports show substantial differences in
frequencies of CM treatments among the
Nordic countries, varying from 18.3 cases per
100 completed or terminated lactations in Swe-
den (Swedish Dairy Association, 2002) to 25.8
per 100 cow-years in Norway (Norwegian Cat-
tle Health Services, 2002). Whether the calcu-
lated CM frequencies reﬂect the true risks ofCM depends on several factors, which could be:
1. Differences in calculation techniques used
when presenting risk rates
2. Differences in the use of diagnostic criteria
for mastitis classiﬁcation
3. Differences in the efﬁciency and accuracy
of the recording systems
4. Differences in the farmers' propensity to
treat mastitis given different signs of dis-
ease and at different times during lactation
5. Differences in age distribution in different
populations
It is difﬁcult to compare the countries' disease
levels because different methods are used for
calculating national mastitis treatment rates.
According to an International Dairy Federation
(IDF) report, the choice of calculation tech-
nique could account for up to 30% of the re-
ported differences in disease levels between
countries (IDF, 1997). Another study has de-
monstrated that calculated disease rates may
vary more than 55% depending on the methods
used when calculating disease occurrence in the
same population. (Larssen et al. 2000). There
are also differences in case deﬁnitions of masti-
tis, populations at risk and the deﬁnition of new
cases versus recurring cases. The organization
of the recording system may also inﬂuence the
correctness of the calculated CM frequencies.
The objective of the retrospective observational
cohort study presented here was to use a uni-
form approach to calculate lactation-speciﬁc
cumulative incidence risk of mastitis treatments
in Denmark, Finland, Norway and Sweden in
order to compare and discuss possible reasons
for any observed differences between the coun-
tries. In addition, risks of being removed from
the herds are compared and discussed, as mas-
titis is one of the main reasons for removal.
Materials and methods
Selection of Data
Disease data were obtained from each country's
dairy cow recording system according to jointly
agreed standard criteria. The national dairy cow
recording systems comprised 84% of the herds
and 88% of the cows in Denmark (Kvaeg-
databasen), 64% of the herds and 70% of the
cows in Finland (Kudatabasen), 87% of the
herds and 92% of the cows in Norway (Kukon-
trollen) and 73% of the herds and 79% of the
cows in Sweden (Kodatabasen). Herds were se-
lected by a random procedure so that at least
50,000 cows from each country were included.
In Finland all herds in the database were in-
cluded in the analyses. All cows from the se-
lected herds that calved at least once during
1997 were included. For each cow, information
was obtained on calving date in 1997, parity,
date of removal, disease date and disease code.
The date of subsequent calving was also in-
cluded. The data were checked for logical er-
rors and unlikely values. For instance, records
with culling date earlier than calving date were
excluded. Six cows were excluded from the
Norwegian dataset for this reason, none from
the Swedish and 6 from the Danish dataset.
Logical errors were automatically corrected in
the Finnish database and no exclusions from the
selected dataset were necessary. Unlikely val-
ues could be due to typing errors. A calving in-
terval of less than 151 days was regarded as an
abortion, and such records were excluded from
the analyses. The numbers of cows excluded
due to a calving interval of less than 151 days
were 6 (0.011%), 43 (0.014%) and 6 (0.011%)
in Denmark, Finland and Norway respectively.
As the Swedish data had been checked for calv-
ing interval prior to selection, information on
the number of cows excluded was not available
in the dataset.
Each cow was monitored from 15 days before
calving until either the ﬁrst case of mastitis, re-
moval or day 305 of lactation. Cows that calved
a second time at the end of the year and thus
started a new lactation were monitored through
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1997 comprised 1.7 %, 1.2 %, 0.9 %, and 1.0 %
of the cows in Denmark, Finland, Norway and
Sweden, respectively.
Mastitis treatments were categorized differ-
ently in the Nordic countries: the Swedish
recording system had only 2 main codes for
mastitis but used an additional code to denote
dry cow therapy, while the Danish recording
system split mastitis into 7 different sub-diag-
noses and the veterinarians can choose either to
use the code "mastitis" or one of the other codes
which add more information to the record. The
disease codes used for mastitis treatments in
this study are presented in Table 1. 
Risk of mastitis treatment
The mastitis risks were estimated separately for
each parity group and country. The ﬁnal dataset
contained, for each day of lactation and parity
group, the number of cows at risk, the number
of removed cows and the number of mastitis
treatments. For each day X of lactation the ex-
act risk of mastitis treatment was calculated as
the number of new treatments on day X divided
by the number of cows at risk. The cumulative
incidence risk of mastitis treatments was calcu-
lated according to Kleinbaum et al. (1982) as:
1-[(1-cumulative risk of mastitis on day X-
1)*(1-risk of mastitis on day X)] and presented
graphically as the lactation-speciﬁc cumulative
risk of mastitis treatments throughout lactation
(until day 305 of lactation).
To illustrate the differences in mastitis risks be-
tween countries, the relative risks of mastitis
treatments were calculated. The country with
the lowest risk was chosen as the baseline, and
the relative risk for each day in lactation was
calculated as the cumulative risk of mastitis that
particular day divided by the cumulative risk of
mastitis in the country with the lowest level.
The results were presented graphically as the
relative risk of mastitis treatments throughout
lactation. 
Similarly, the differences in mastitis treatment
risks between ﬁrst and second parity cows were
presented graphically for each country as the
relative risk of mastitis treatments (second par-
ity cows vs. ﬁrst parity cows) throughout lacta-
tion.
Risk of removal
Risk of removal was calculated by means of cu-
mulative risk in the same way as for mastitis. In
this context, removal comprised both removal
for trade and removal for slaughter.
Data analyses
Descriptive analyses were performed using
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Table 1. Disease codes used for mastitis treatments
in the Nordic countries' national dairy cow recording
systems for 1997.
Country Disease code Description
Denmark 11 Mastitis
12 Mastitis in dry period
13 Dry cow therapy
14 Mastitis and teat lesion
15 Acute mastitis
72 Summer mastitis
94 Toxic mastitis
95 Subclinical mastitis
Finland 301 Acute clinical mastitis
302 Subclinical mastitis
303 Chronic mastitis
821 Dry cow therapy
Sweden 270 Mastitis
601 Mastitis and teat injury
270+
subcode 6 Dry cow therapy
Norway 303 Acute clinical mastitis*
304 Chronic clinical mastitis**
305 Subclinical mastitis
* Changed to severe/moderate clinical mastitis (303) and
**changed to mild clinical mastitis (304) in 1999.PROC MEAN and PROC FREQ in the soft-
ware programme SAS (SAS Institute Inc.
1990). 
Results
Descriptive statistics
Descriptive statistics for herd variables are
given in Table 2. The average number of cows
per herd included in the analyses was 66.5 in
Denmark, 15.6 in Finland, 15.7 in Norway and
34.5 in Sweden.
The distribution of cow age measured as parity
number is shown in Fig. 1. Finland had more
cows in higher parity groups than the other
countries. In fact 12.0% of the cows in Finland
started their ﬁfth or higher lactation during the
study year, compared to 9.7% in Denmark,
8.8% in Norway and 10.8% in Sweden. Norway
had the highest proportion of cows in ﬁrst lac-
tation (37.8%) while Finland had the lowest
proportion (34.0%). The percentages in Den-
mark and Sweden were 37.7 and 35.0, respec-
tively.
The distribution of calving by month is shown
in Figure 2. There was an increase in number of
calvings in August, September and October in
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Table 2. Descriptive statistics of herd variables in the data sets from the national dairy cow recording systems
for 1997.
Number of Number of Number of Average number
herds selected cows included started lactations of cows per herd
Denmark 812 53,959 54,894 66.5
Finland 18,887 293,781 297,355 15.6
Norway 3,573 55,976 56,486 15.7
Sweden 2,132 73,599 74,370 34.5
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Figure 1. Parity distribution (per cent) by country for lactations started in 1997 among cows in the Nordic
countries.
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yall countries except Denmark. This increase
was more pronounced in Norway than in Swe-
den and Finland. Denmark had the highest birth
rate for calves in March.
Mastitis treatment risk
The lactation-speciﬁc cumulative risk of
recorded mastitis treatments during 305 days of
lactation is given in Fig. 3 - 6 for Denmark, Fin-
land, Norway and Sweden, respectively.
The lowest risk of recorded mastitis treatments
during 305 days of lactation was found in Swe-
den (Fig 6). The risk varied from 0.127 among
ﬁrst parity cows to 0.204 in parities higher than
3. The highest incidence risk was recorded in
Norway, with 0.215 in ﬁrst parity cows and
0.358 in parities higher than 3 (Fig 5). The inci-
dence risk of mastitis during 305 days of lacta-
tion in Denmark was 0.177 for ﬁrst parity cows
and 0.228 for parities higher than 3 (Fig 3). In
Finland the incidence risk was 0.139 for ﬁrst
parity cows and 0.215 for parities higher than 3
(Fig 4). The cumulative risk curves were simi-
lar in all countries; however, the data from Den-
mark and Finland showed a slight increase in
mastitis risk from day 270 (Fig 3 and 4). 
The risk of mastitis treatments for ﬁrst parity
cows in Denmark, Finland and Norway relative
to Sweden is shown in Fig. 7. The risk of a cow
being treated for mastitis was almost 3 times
higher at calving in Norway than in Sweden.
The risk of mastitis treatments in Norway also
showed a pronounced increase on calving day
relative to Denmark and Finland. Denmark had
a marked peak in relative risk of mastitis treat-
ments (RR = 2.50) 11 days before calving com-
pared to Sweden. Finland had an increase in the
risk of mastitis treatments from 15 to 60 days
into ﬁrst lactation relative to Sweden. After 305
days in lactation, the relative risk of mastitis
therapy compared to Sweden was 1.09 for Fin-
land, 1.40 for Denmark and 1.70 for Norway.
The period with the highest risk was from 2
days before calving until 14 days after calving
for all countries.
The risk of mastitis treatments for ﬁrst parity
cows were higher than the risk for second par-
ity up to day 45, 64, 22 and 58 in Denmark, Fin-
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Figure 2. Birth distribution by country and month for calves born in 1997.
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Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9land, Norway and Sweden respectively (Fig. 3 -
6). The risk curves for ﬁrst lactation also ex-
ceeded the risk curves for third lactation in the
period from 1 day before calving to day 21 in
Finland and day 1 to 4 in Sweden (Fig. 4 and 6).
The risks of mastitis treatments in ﬁrst lactation
relative to the risks in second lactation during
the ﬁrst 3 months in milk are given in Fig 8.
Removal from the herd
The cumulative risk of removal by 305 days of
lactation is given in Fig. 9. The risk of removal
over all lactations was 0.239, 0.239, 0.303, and
0.202 in Denmark, Finland, Norway and Swe-
den respectively. The period with the highest
risk for removal was from calving to 10 days af-
ter calving in all countries. The risk curves were
ﬂattest in the period from approximately 10 to
160 days of lactation indicating a higher daily
incidence risk outside this time interval. This
was more pronounced in Sweden than in the
other countries. The risk curve for Denmark
showed a decrease in risk of removal in the 4th
lactation month.
Discussion
Our study demonstrated considerable differ-
ences in recorded mastitis treatment risks be-
tween the Nordic countries. The calculated
risks were based on data routinely collected by
farmers and veterinarians, and our results could
be biased if there were different recording or re-
porting rates between the countries.
In the Nordic countries, administration of an-
tibiotics to dairy cows is strictly regulated. Only
veterinarians are allowed to initiate mastitis
treatments using antibiotics. Recording and re-
porting is compulsory when a veterinarian is
called to a mastitis case, which yields a higher
mastitis reporting rate than if the treatments
were at the discretion of the farmers. In general,
correct information on prevalence and inci-
dences of diseases in cattle in the dairy industry
is difﬁcult to obtain. To a large extent, the
Nordic countries are the only countries world-
wide that have a system for annual reporting of
treatment rates and risks. The disease recording
systems form the basis for health monitoring at
the local, regional and national level. It pro-
vides sufﬁcient data to estimate disease fre-
quencies in each country (Olsson et al. 2001).
The Norwegian dairy cow recording system
was evaluated in a study in 2000 (Østerås &
Grave 2002). This study found no signiﬁcant
difference in the incidence rate of mastitis be-
tween herds that were monitored intensively
compared to herds that were monitored through
the regular health recording system. Thus, these
ﬁndings indicated that the Norwegian dairy
cow recording system is of good quality.
The differences in diagnostic criteria between
the countries were managed by using a broad
deﬁnition of mastitis in this study. Within each
country, all mastitis treatments, irrespective of
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Figure 3. Parity speciﬁc cumulative risk of bovine
mastitis treatments, in Denmark based on data from
the national dairy cow recording system for 1997.
Figure 4. Parity speciﬁc cumulative risk of bovine
mastitis treatments, in Finland based on data from the
national dairy cow recording system for 1997.
Figure 5. Parity speciﬁc cumulative risk of bovine
mastitis treatments, in Norway based on data from
the national dairy cow recording system for 1997.
Figure 6. Parity speciﬁc cumulative risk of bovine
mastitis treatments, in Sweden based on data from
the national dairy cow recording system for 1997.
Figure 7. Relative risk of mastitis treatments for
ﬁrst parity cows in 1997 in Denmark, Finland and
Norway compared to Sweden as baseline.
Figure 8. Risk of mastitis treatments in ﬁrst lactat-
ing cows relative to the risk in second lactation
among the Nordic countries in 1997.
Figure 9. Cumulative risk of removal for cows that
started a new lactation in 1997.their designated disease code, were merged into
one group. Thus, the diagnostic criteria became
as identical as possible in all countries. Dry cow
therapy was also included in the mastitis group.
As shown in Table 2, there was no harmoniza-
tion with respect to mastitis nomenclature
within the Nordic countries. This table illus-
trates the need to adapt the recent IDF recom-
mendations for mastitis nomenclature (IDF,
1997).
One crucial factor contributing to the apparent
differences in mastitis treatment risks could be
the farmers' treatment strategy. The true risk of
a cow contracting mastitis may not vary as
much as the data in this study indicated, but the
risk of being treated for mastitis – and thus be-
ing reported – may vary signiﬁcantly depending
on the farmer's propensity to choose different
treatment strategies for mastitis. (e.g. culling,
drying off diseased quarters, frequent milking).
Thus the calculated risks should not be re-
garded as the true risks of mastitis, but rather as
measures of the degree of investment in veteri-
nary treatments of mastitis. The calculated risks
will thus be a combination of the level of infec-
tion (which is due to exposure or lack of expo-
sure to certain risk factors), the farmers' ability
to detect mastitis and their management strate-
gies. It should be noted that the mastitis treat-
ment rate has decreased dramatically in Nor-
way in recent years, with a decline in the annual
incidence rate from 0.42 cases of mastitis treat-
ments per cow-year in 1997 to 0.28 cases per
cow-year in 2001 (Norwegian Cattle Health
Services, 2002, annual report).
Quality payment schemes may inﬂuence the
farmers' ability and willingness to treat their
cows. For example, increasing demands from
the dairy industry to keep the BMSCC at a low
level may lead to a higher frequency of mastitis
treatments. Such requirements vary between
countries. Mastitis treatment can thus be re-
garded as an investment in production to
achieve good quality milk in terms of somatic
cell count.
Incidence rates deﬁned as number of new cases
per cow-day at risk may be inﬂuenced by popu-
lation age distribution and average length of
lactations. The fact that the risk of CM treat-
ments is highest around calving (Barkema et
al., 1998) and increases by parity suggests that
lactation-speciﬁc cumulative incidence should
be used when comparing mastitis levels be-
tween different countries. Using this approach,
differences in parity distribution between the
countries will not bias the results and equiva-
lent calculation procedures are ensured. 
The risk of mastitis treatments varied according
to parity and lactation stage. Older cows were at
higher risk of mastitis than younger cows, and
cows around calving were at higher risk than
cows later in lactation. In a cow population with
a high culling/replacement rate one would ex-
pect to ﬁnd higher incidence rates of mastitis
than in a population with low culling rate, be-
cause the distribution of cows over the days in
lactation would be skewed towards the early
postpartum period. On the other hand, in a cow
population with a high culling rate the cows
will be younger and less susceptible to mastitis,
and this may in turn lead to a lower incidence
rate. In this study, mastitis risk was calculated
for each lactation and presented as cumulative
risk of mastitis treatments from 15 days before
calving to 305 days after calving and thereby
controlled for any differences in distribution of
parity or stage in lactation.
Risk of mastitis by 305 days of lactation in-
creased with increased parity. However, the risk
of mastitis in heifers was higher than the risk in
second parity cows early in lactation. In Finland
and Sweden, the risk of heifer mastitis was even
higher than in third-parity cows up to day 4 in
Sweden and day 21 in Finland. This was an in-
teresting ﬁnding and must be seen in relation to
culling strategies. Heifers treated for mastitis in
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did not reach second lactation at all. The aver-
age mastitis resistance early in lactation would
then be higher in second-parity cows than in
ﬁrst-parity cows. If this is true, mastitis early in
lactation must be caused by other risk factors
than mastitis later in lactation. The high risks of
mastitis in ﬁrst lactation relative to the risks in
second lactation in Sweden and Finland (Fig 8)
may indicate that heifers were exposed to more
unfavourable environmental factors compared
to older cows in these 2 countries.
Data from all the Nordic countries demon-
strated an elevated risk of mastitis treatments
around calving. Fifty per cent of the treatments
in ﬁrst lactation were administered before day
36 in Denmark, day 13 in Finland, day 17 in
Norway and day 39 in Sweden. Understanding
why the distribution of mastitis treatments were
skewed more towards the ﬁrst 2 weeks of lacta-
tion in Finland and Norway compared to Den-
mark and Sweden requires further research.
Part of the reason may be that Norway and Fin-
land have by far the smallest herds among the
Nordic countries (Table 2). Thus, the BMSCC
are relatively more vulnerable to sudden in-
creases in individual SCC. The farmers may
therefore monitor the milk more closely during
the colostrum period before it goes into the bulk
tank and small deviances from normal values
may lead to treatment. In small herds it may be
more common to monitor each cow using indi-
vidual CMT-tests just after calving. The use of
CMT-scores at farm level, which is common in
Norway, could be one of the reasons for the rel-
atively large difference in mastitis treatment
risk between Norway and the other countries,
provided that the use of CMT scores lead to
more frequent treatments.
The risk of mastitis showed a marked increase
from around day 270 both in Finland (Fig 4)
and in Denmark (Fig 3). In Finland this was due
to dry cow therapy, but in Denmark only 312
cases were related to dry cow treatment, which
had no effect on the risk calculated – due to the
large amount of data. The fact that Norway and
Sweden did not have a separate disease code for
dry cow therapy indicates that these two coun-
tries devoted less attention to and did not rec-
ommend dry cow therapy as much as in Fin-
land.
Both risk of removal from the herd and mastitis
treatment risk were highest in Norway and low-
est in Sweden. A cost-effective curve of optimal
culling indicated that the selection of cows for
culling should be done between the 3rd and 5th
month of ﬁrst lactation and that replacement
costs increase after the 5th or 6th lactation
month (Østerås 2000). Fig 9 demonstrates that
the risk of removal was evenly distributed
throughout lactation in Norway, while the
curves for Sweden and Finland showed an in-
crease towards the end of lactation. The risk
curve for Denmark showed a decrease in risk of
removal in the 4th lactation month, hence the
risk of removal was lowest when the replace-
ment cost was lowest. Removal early in lacta-
tion is probable necessitated by disease prob-
lems. Removal late in lactation could be due to
cows failing to conceive. Differences in prices
of meat and milk, production subsidies and
milk quotas also inﬂuence the risk of removal.
Our study clearly demonstrated differences in
bovine mastitis treatment patterns between the
Nordic countries. The most interesting ﬁndings
were the differences in treatment risks during
different lactations within each country, as well
as differences in strategies with respect to the
time during lactation mastitis was treated. In
this study bias caused by effects from data ex-
traction, calculations, age and stage of lactation
and different diagnostic codes was controlled
during the process. Further research is neces-
sary to obtain more thorough knowledge about
the differences in mastitis treatment risks
among the Nordic countries.
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Sammendrag
Kumulativ risiko for mastittbehandlinger i Danmark,
Finland, Norge og Sverige.
Nasjonale kukontolldata ble brukt til å kalkulere ku-
mulativ risiko for mastittbehandlinger og kumulativ
risiko for utrangering i Danmark, Finland, Norge og
Sverige. Den lågeste risikoen for mastitt i løpet av
305 dager i laktasjon ble funnet i Sverige hvor
risikoen varierte fra 0,127 for kyr i første laktasjon til
0,204 for fjerdelaktasjonskyr og eldre. Den største
risikoen ble funnet i Norge med 0,215 for kyr i første
laktasjon og 0,358 for fjerdelaktasjonskyr og eldre.
Tilsvarende tall for Danmark og Finland var hen-
holdsvis 0,177 og 0,139 for førstekalvs kyr og 0,228
og 0,215 for fjerdelaktasjonskyr og eldre. Risikoen
for mastitt i første laktasjon var nesten 3 ganger
større omkring kalving i Norge enn i Sverige.
Risikoen for en mastittbehandling i Norge viste også
en markert økning på kalvingsdagen sammenliknet
med de andre landene i Norden. Størst risiko for mas-
tittbehandling var i perioden fra 2 dager før kalving
til 14 dager ut i laktasjonen og størst risiko for
utrangering var fra kalving til 10 dager ut i laktasjo-
nen for alle land. Undersøkelsen fant klare forskjeller
i mastittmønsteret i de nordiske land. De viktigste
funnene var forskjellene i behandlingsrisiko for mas-
titt mellom de ulike laktasjonene innenfor hvert land
og forskjellene i behandlingsstrategi landene i mel-
lom med hensyn på tidspunktet i laktasjonen risikoen
for mastittbehandling var størst.
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